125 related articles for article (PubMed ID: 2471507)
1. Kawasaki disease, oxygen radicals and high dose gammaglobulin therapy.
Kuratsuji T; Shinomiya N; Kobayashi N; Takagi K; Shimizu S; Ojima T; Takahashi E; Hanabusa H
Basic Life Sci; 1988; 49():997-1003. PubMed ID: 2471507
[No Abstract] [Full Text] [Related]
2. Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.
Nishihara S; Ishibashi K; Iribe K; Matsuda I
Lancet; 1988 Oct; 2(8617):973. PubMed ID: 2459575
[No Abstract] [Full Text] [Related]
3. Enzyme release and O2 production of neutrophils and vascular lesions in gamma globulin therapy of Kawasaki disease.
Okazaki T; Sakatani T; Sasagawa S; Ohta H; Ohnishi H; Suzuki K
Prog Clin Biol Res; 1987; 250():557-8. PubMed ID: 3423073
[No Abstract] [Full Text] [Related]
4. [Gamma globulins and Kawasaki disease].
Musumeci S; Fischer A; Di Dio R
Pediatrie; 1986 Jun; 41(4):333-5. PubMed ID: 2433677
[No Abstract] [Full Text] [Related]
5. High-dose intravenous gammaglobulin for Kawasaki disease.
Furusho K; Sato K; Soeda T; Matsumoto H; Okabe T; Hirota T; Kawada S
Lancet; 1983 Dec; 2(8363):1359. PubMed ID: 6196587
[No Abstract] [Full Text] [Related]
6. Differences in oxygen metabolism of phagocytosing monocytes and neutrophils.
Reiss M; Roos D
J Clin Invest; 1978 Feb; 61(2):480-8. PubMed ID: 202614
[TBL] [Abstract][Full Text] [Related]
7. Pathways of oxygen utilization by stimulated platelets and leukocytes.
Marcus AJ
Semin Hematol; 1979 Jul; 16(3):188-95. PubMed ID: 225828
[No Abstract] [Full Text] [Related]
8. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Terai M; Jibiki T; Harada A; Terashima Y; Yasukawa K; Tateno S; Hamada H; Oana S; Niimi H; Matsushima K
J Leukoc Biol; 1999 May; 65(5):566-72. PubMed ID: 10331483
[TBL] [Abstract][Full Text] [Related]
9. Measurement of oxidizing radicals by polymorphonuclear leukocytes.
Clifford DP; Repine JE
Methods Enzymol; 1984; 105():393-8. PubMed ID: 6328192
[TBL] [Abstract][Full Text] [Related]
10. Reactions of myeloperoxidase with superoxide and hydrogen peroxide: significance for its function in the neutrophil.
Winterbourn CC; Kettle AJ
Basic Life Sci; 1988; 49():823-7. PubMed ID: 2855005
[No Abstract] [Full Text] [Related]
11. High-dose gammaglobulin therapy for Kawasaki disease.
Nagashima M; Matsushima M; Matsuoka H; Ogawa A; Okumura N
J Pediatr; 1987 May; 110(5):710-2. PubMed ID: 2437278
[TBL] [Abstract][Full Text] [Related]
12. Phagocytes use oxygen to kill bacteria.
Baggiolini M
Experientia; 1984 Sep; 40(9):906-9. PubMed ID: 6088281
[No Abstract] [Full Text] [Related]
13. Kawasaki syndrome in 18 children in the west of Scotland.
Odaibo FS; Goel KM
Scott Med J; 1991 Aug; 36(4):107-9. PubMed ID: 1720900
[TBL] [Abstract][Full Text] [Related]
14. Differences in immunoglobulin preparations and outcome of Kawasaki disease.
Yavuz H; Ozel A
J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453
[No Abstract] [Full Text] [Related]
15. Kawasaki syndrome: clinical features. Pathophysiology, etiology and therapy.
Melish ME; Hicks RV
J Rheumatol Suppl; 1990 Sep; 24():2-10. PubMed ID: 1700121
[No Abstract] [Full Text] [Related]
16. High-dose intravenous gammaglobulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Lancet; 1984 Nov; 2(8411):1055-8. PubMed ID: 6209513
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of cat-scratch disease bacilli.
Fumarola D; Giuliani G; Petruzzelli R; Partipilo MR; Pece S
Pediatr Infect Dis J; 1994 Feb; 13(2):162-3. PubMed ID: 8190547
[No Abstract] [Full Text] [Related]
18. Evaluation of the cytokine response in Kawasaki disease.
Eberhard BA; Andersson U; Laxer RM; Rose V; Silverman ED
Pediatr Infect Dis J; 1995 Mar; 14(3):199-203. PubMed ID: 7539120
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-8 in Kawasaki disease.
Asano T; Ogawa S
Clin Exp Immunol; 2000 Dec; 122(3):514-9. PubMed ID: 11122263
[TBL] [Abstract][Full Text] [Related]
20. Chemiluminescence of human bloodstream monocytes and neutrophils: an unusual oxidant(s) generated by monocytes during the respiratory burst.
Davies B; Edwards SW
J Biolumin Chemilumin; 1992 Oct; 7(4):229-38. PubMed ID: 1332430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
